MK801 influences l-DOPA-induced dopamine release in intact and hemi-parkinson rats

By Jonkers N.   Sarre S.   Ebinger G.   Michotte Y.  

European Journal of Pharmacology, Vol. 407, Iss. 3, 2000-11 ,pp. : 281-291

Elsevier

Access to resources Recommend Favorite

Levodopa biotransformation in hemi-Parkinson rats: effect of dopamine receptor agonists and antagonists

By Sarre S.   Ebinger G.   Michotte Y.  

European Journal of Pharmacology, Vol. 296, Iss. 3, 1996-02 ,pp. : 247-260

Elsevier

Access to resources Recommend Favorite

Cell Suspension Cultures of Portulaca grandiflora as Potent Catalysts for Biotransformation of L-Tyrosine into L-DOPA, an Anti-Parkinson's Drug

By Rani Nisha   Joy Beena   Abraham T. Emilia  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 45, Iss. 1, 2007-01 ,pp. : 48-53

Informa Healthcare

Access to resources Recommend Favorite

Muscarinic antagonists in substantia nigra influence the decarboxylation of l-dopa in striatum

By Izurieta-Sanchez P.   Sarre S.   Ebinger G.   Michotte Y.  

European Journal of Pharmacology, Vol. 399, Iss. 2, 2000-07 ,pp. : 151-160

Elsevier

Access to resources Recommend Favorite

Transdermal absorption of l-dopa from hydrogel in rats

By Lindner A.   Sudo J.-i.   Iwase H.   Terui J.   Kakuno K.   Momoko Soyama   Takayama K.   Nagai T.  

European Journal of Pharmaceutical Sciences, Vol. 7, Iss. 1, 1998-12 ,pp. : 67-71

Elsevier

Access to resources Recommend Favorite